CYBERDYNE Inc. (JP:7779)
:7779
7779 Stock Chart & Stats
¥216.00
-¥5.00(-2.72%)
At close: 4:00 PM EST
¥216.00
-¥5.00(-2.72%)
Day’s Range― - ―
52-Week Range¥147.00 - ¥420.00
Previous CloseN/A
Volume1.10M
Average Volume (3M)724.97K
Market Cap
¥60.17B
Enterprise Value¥29.40B
Total Cash (Recent Filing)¥9.20B
Total Debt (Recent Filing)¥434.00M
Price to Earnings (P/E)87.8
Beta0.87
Next Earnings
May 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.57
Shares Outstanding137,445,820
10 Day Avg. Volume764,380
30 Day Avg. Volume724,970
Financial Highlights & Ratios
PEG Ratio1.05
Price to Book (P/B)0.93
Price to Sales (P/S)8.43
P/FCF Ratio-50.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥410.00Price Target Upside89.81% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.13
Revenue Forecast (FY)¥4.20B
Bulls Say, Bears Say
Bulls Say
Strong Balance Sheet / Low LeverageVery low debt relative to equity and a stable asset base provide durable financial flexibility. This allows the company to fund R&D, support commercialization of HAL, and absorb near-term cash shortfalls without immediate refinancing, reducing execution risk over the next 2–6 months.
Healthy, Stable Gross MarginsSustained gross margins in the 50–70% range indicate durable unit economics for the HAL platform and related services. High product/service margins create a structural opportunity to reach operating profitability as revenue scales and fixed costs are leveraged, supporting long-term margin sustainability.
Proprietary Core Product With Recurring Service ModelOwning the HAL exoskeleton and combining device sales/leasing with training, maintenance, and program fees builds recurring revenue potential and customer lock-in. This integrated business model supports durable revenue streams tied to rehabilitation demand and aftermarket services over midterm horizons.
Bears Say
Persistent Net Losses And Negative Cash FlowOngoing net losses and negative operating/free cash flow mean the business is not yet self-funding. Even with reduced TTM cash burn, sustained deficits constrain reinvestment, increase reliance on external financing, and raise execution risk for scaling commercialization over the next several months.
Near-term Revenue Momentum SoftenedA recent reversal in revenue momentum—TTM decline after prior multi-year growth—signals adoption or distribution friction. Slowing top-line growth undermines leverage of fixed costs and delays achieving operating profitability, making near-term improvement dependent on regained sales traction.
Reimbursement And Adoption DependencyRevenue and profitability are structurally sensitive to reimbursement decisions and provider adoption cycles. Delays or adverse changes in insurance coverage, regulatory approvals, or partner rollout can materially slow sales and service uptake, creating medium-term demand risk for HAL deployments.
CYBERDYNE News
7779 FAQ
What was CYBERDYNE Inc.’s price range in the past 12 months?
CYBERDYNE Inc. lowest stock price was ¥147.00 and its highest was ¥420.00 in the past 12 months.
What is CYBERDYNE Inc.’s market cap?
CYBERDYNE Inc.’s market cap is ¥60.17B.
When is CYBERDYNE Inc.’s upcoming earnings report date?
CYBERDYNE Inc.’s upcoming earnings report date is May 14, 2026 which is in 48 days.
How were CYBERDYNE Inc.’s earnings last quarter?
CYBERDYNE Inc. released its earnings results on Feb 12, 2026. The company reported ¥0.57 earnings per share for the quarter, beating the consensus estimate of N/A by ¥0.57.
Is CYBERDYNE Inc. overvalued?
According to Wall Street analysts CYBERDYNE Inc.’s price is currently Undervalued.
Does CYBERDYNE Inc. pay dividends?
CYBERDYNE Inc. does not currently pay dividends.
What is CYBERDYNE Inc.’s EPS estimate?
CYBERDYNE Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CYBERDYNE Inc. have?
CYBERDYNE Inc. has 137,445,820 shares outstanding.
What happened to CYBERDYNE Inc.’s price movement after its last earnings report?
CYBERDYNE Inc. reported an EPS of ¥0.57 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 13.074%.
Which hedge fund is a major shareholder of CYBERDYNE Inc.?
Currently, no hedge funds are holding shares in JP:7779
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CYBERDYNE Inc.
CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains equipment and systems for medical and warfare in Japan. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; and Acoustic X, a high speed light pulse LED array light source that enables real time photoacoustic imaging. It also provides Cybernics Treatment, a treatment that uses HAL to enhance/regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; HAL FIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes' brain-nerve functions; and Neuro HALFIT for enhancement of physical functions. In addition, the company is involved in the provision of rescue supports in disaster sites, and heavy labor supports for factories and plants; and entertainment business. The company was incorporated in 2004 and is headquartered in Tsukuba, Japan.
7779 Stock 12 Month Forecast
Average Price Target
¥410.00
▲(89.81% Upside)
Technical Analysis
PHC Holdings Corp.
―
Create Medic Co., Ltd.
―
Nihon Kohden Corporation
―
Japan Medical Dynamic Marketing, Inc.
―
Koken Ltd.
―
Options Prices
Currently, No data available
---